Gene Query: CCL28

Dataset Description Geneva Score
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 54.58
HNF1 regulates critical functions of the human epididymis epithelium. 39.61
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 39.61
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 29.02
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 29.02
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 24.54
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 24.54
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 21.02
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 18.77
A practical evaluation of alignment algorithms for RNA variant calling analysis 16.13
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 14.18
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 12.67
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 12.67
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 11.98
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 11.98
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 11.81
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 11.53
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 11.31
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 11.04
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.61
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 10.05
Fusion discovery in breast cancer cell line 9.85
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 9.47
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 9.42
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 9.32
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 9.08
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 8.34
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.23
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 7.65
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 7.49
ChIP-seq and RNA-seq from human lymphoma cell lines 7.42
RNA-seq data from human lymphoma cell lines 7.42
mRNA-sequencing of breast cancer subtypes and normal tissue 7.12
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.97
Preclinical model of obesity and ER-positive breast cancer 6.74
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.74
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.64
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 6.52
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 6.46
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 6.45
Epigenetic reprogramming of melanoma cells by vitamin C treatment 6.44
RNAseq analysis of ruxolitinib treated breast cancers 6.03
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 5.88
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 5.79
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 5.48
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 5.42
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 5.35
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 5.3
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.17
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.15
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.07
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 4.97
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 4.78
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 4.74
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.57
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.4
mRNA sequencing analysis of cultured human primary airway epithelial cells upon exposure to PMN exosomes 4.37
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 4.37
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 4.07
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.07
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.03
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 3.95
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 3.93
Persistence of stem cell metabolism in cancers as a failure of differentiation 3.89
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.82
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.6
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.42
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.32
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 3.28
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.21
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.2
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 3.2
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.09
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 3.05
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.01
Gene expression alterations of pancreatic intraepithlial neoplasia 2.98
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.97
Universal alternative splicing of noncoding exons 2.94
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 2.94
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 2.94
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 2.93
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 2.9
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 2.89
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 2.86
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 2.86
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.82
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.82
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 2.8
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.78
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.77
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.71
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.71
RNA-seq differential expression studies: more sequence, or more replication? 2.7
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 2.69
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 2.69
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.68
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.68
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 2.67
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 2.67
Gene expression analysis of human liver progenitor-like cells in culture 2.65
RNA-sequencing 2.64
Reassessment of Exosome Composition 2.58
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 2.53
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.53
Differentially expressed genes post knock down of lincDUSP26 2.52
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.5
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.49
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.38
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.29
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.28
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 2.27
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.27
Gene expression analysis in response to hypoxic pathway inhibition 2.26
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.2
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 2.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.18
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 2.1
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 2.1
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.07
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.07
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.07
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 2.0
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.98
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 1.95
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.93
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.93
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 1.93
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.92
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.92
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.92
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.92
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 1.92
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 1.9
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.88
The gene expression profiles of gallbladder cancer 1.88
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.88
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.87
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.87
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.85
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.85
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.84
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 1.83
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.81
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 1.79
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 1.77
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 1.76
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 1.76
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.75
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.74
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 1.71
Human neutrophil genome during PMA- and E. coli encounter-induced activation 1.71
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.71
Pharmacologic inhibition of STAT5 in AML 1.7
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 1.7
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.7
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 1.67
HNF1A deficiency impairs β-cell fate, granule maturation and function 1.66
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 1.6
circRNA-sequencing 1.58
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.56
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.56
Gene expression analysis of immortalized human liver progenitor-like cells in culture 1.55
Single cell transcriptome of peritoneal cells 1.53
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 1.52
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 1.52
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.52
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.52
Patient-derived luminal breast cancer xenografts with progestins 1.49
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.49
Common inflammatory pathways between NEC and Crohn's disease 1.48
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 1.47
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.47
SF3B1 Degron knockdown RNA-seq 1.46
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 1.45
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 1.45
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 1.45
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.44
Regulation of hypoxia-inducible factor activity by ZMYND8 1.44
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.42
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 1.41
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 1.41
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 1.39
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.38
Targeting MTHFD2 in Acute Myeloid Leukemia 1.38
CROP-Seq in Primary Human T Cells 1.37
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.36
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 1.35
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.34
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 1.34
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 1.33
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.31
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.31
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 1.28
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 1.28
Identification of renal resident macrophages across species 1.28
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.25
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.23
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.23
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 1.22
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 1.22
The evolution of N6-methyladenosine in primates 1.2
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 1.2
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.17
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.16
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.15
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.13
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.11
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 1.11
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 1.11
RNA m5C Methylation in breast cancer using MeRIP-Seq 1.11
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 1.11
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.1
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 1.1
Identification of global regulators of T-helper cell lineage specification 1.09
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.09
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 1.09
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 1.08
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 1.08
Effect of nuclear IL-33 on gene expression 1.08
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.08
Gene expression analysis of human adenomas. 1.07
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.07
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.07
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 1.06
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.06
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.06
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.06
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.06
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.06
T47D RNA-seq and ChrRNA-seq data 1.06
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 1.06
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.05
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 1.05
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 1.05
Neonatal and adult human testis defined at the single-cell level 1.04
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 1.04
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 1.03
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 1.03
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.03
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.03
Cell responses to dysregulated VZV-induced cell-cell fusion 1.02
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.02
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.02
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.02
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 1.02
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 1.02
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.01
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 0.99
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 0.99
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 0.99
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.99
U1 snRNP telescripting regulates size-function stratified human genome 0.99
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.99
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.99
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 0.98
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.97
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.97
BACH2 in human plasma cell fate decision 0.97
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 0.97
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 0.97
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 0.96
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 0.95
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 0.95
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.94
HEK293 Heat-shock experiment 0.94
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.94
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.94
The Human Testis Cell Atlas via Single-cell RNA-seq 0.92
Gene expression changes associated with resistance to tagraxofusp (SL-401) 0.92
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.92
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 0.91
RNA sequencing of human pancreatic cancer cell lines 0.9
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.89
Cleavage Factor Im as a key regulator of 3’ UTR length 0.89
Proliferation-correlated expression 0.88
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 0.88
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 0.88
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.87
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.87
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.86
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.86
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.85
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 0.84
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 0.84
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.84
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 0.83
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.83
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.82
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.82
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.82
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.82
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.82
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.81
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.81
Transcriptome analysis of CNS leukemia 0.81
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.81
Characterization of human ILC2 subsets 0.8
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.8
Single-Cell Genotyping of Transcriptomes 0.79
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.79
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.79
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.79
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.79
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 0.78
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 0.78
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 0.78
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 0.77
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.77
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.77
Gene expression profiling of leukemia cells following asparagine depletion 0.76
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 0.76
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.76
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.76
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.75
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 0.75
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.75
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.75
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.73
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.73
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.73
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.73
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.73
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 0.73
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.72
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 0.72
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.72
Transcriptional profile in human S. haematobium infection 0.71
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 0.69
Metastasis in triple-negative breast cancer 0.69
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.69
RNA-seq of cancer cell lines treated with T-025 0.67
RNA-seq of SCLC PDX models treated with EP 0.67
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 0.66
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.66
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.65
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 0.65
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.65
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.64
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 0.64
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.64
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.64
TT-Seq captures the human transient transcriptome 0.64
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.63
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.63
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.62
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.62
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.62
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.6
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.6
RNA-seq analysis and shRNA screen of breast cancer 0.6
RNA-seq analysis of breast cancer 0.6
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.59
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 0.59
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 0.59
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.58
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.58
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.58
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.57
Human islets of varying quality: the good, the (not so) bad and the ugly 0.57
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 0.57
RNA Sequencing of three pairs of gastric cancer 0.54
STX4 Over-Expression in Human islets 0.53
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.53
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.52
A single cell reference map for human blood and tissue T cell activation 0.52
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.5
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.5
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.49
Molecular analysis of renal cell carcinoma with unclassfied histology 0.49
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.48
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.48
Gene expression signatures of innate lymphoid cells from human blood 0.47
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.47
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.46
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.46
RNAseq of Breast cancer PDX samples 0.45
Transcriptome analyses of human pancreatic islets and pseudoislets 0.45
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.44
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.44
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 0.43
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 0.43
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.41
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.41
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.4
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.4
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.39
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 0.39
Non-coding regions are the main source of tumor-specific antigens 0.39
Non-coding regions are the main source of tumor-specific antigens [human] 0.39
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.38
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.38
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 0.37
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 0.36
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 0.36
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.35
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.34
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 0.34
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.33
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.33
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.33
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.32
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.32
Gene expression of collecting duct carcinoma of the kidney 0.32
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.32
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.32
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.3
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.3
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.3
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.3
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.29
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.29
The DNA methylation landscape of human melanoma 0.29
The DNA methylation landscape of human melanoma [RNA-Seq] 0.29
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.28
Identification of long noncoding RNAs in T-ALL cell lines 0.28
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.27
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.27
An optimization system for isolating and sequencing of single human colon cancer cells 0.27
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.26
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.26
Downregulation of LATS kinases alters p53 to promote cell migration 0.24
siRNA-mediated knockdown 0.23
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.23
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.23
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.23
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.23
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.22
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.22
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.21
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.2
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.2
A single-cell transcriptome atlas of the human pancreas 0.2
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.19
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 0.19
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.19
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.19
Primary human trophoblast from term placenta 0.19
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.18
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.18
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.18
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.18
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.18
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.18
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.17
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.17
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.17
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.16
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.16
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.15
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.14
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.14
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.14
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.13
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.12
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.12
RNA-seq data 0.12
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.12
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.1
Energy Metabolism during Anchorage-Independence 0.1
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.1
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.1
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.09
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.09
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.09
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.09
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 0.09
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.08
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.08
MicroRNA-125a-5p overexpression in human macrophages 0.08
RNA sequencing of T-ALL (COG study) 0.08
Analyses of T-ALL (COG study) 0.08
Single-cell analysis of adult human ovary using 10X genomics 0.08
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.08
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.07
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 0.07
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.07
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.06
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.06
Leucegene: ALL sequencing 0.05
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.05
Discovering human diabetes-risk gene function with genetics and physiological assays 0.04
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.04
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.04
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.04
RNA-seq of primary patient AML samples 0.04
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.03
Human Tfh cell RNA bulk sequencing 0.03
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.03
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.03
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.02
Transcriptomic analysis of frontal fibrosing alopecia 0.02
The Genomic Landscape of Atypical Fibroxanthoma 0.02
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.02
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.01
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.01
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation